Clinical Trial Update: NS-050/NCNP-03 in Boys With DMD (Meteor50) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial NS-050/NCNP-03 for Duchenne muscular dystrophy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• NCNP-03
• NS-050

Snippet

Sponsor: NS Pharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING